FAM
ORIC icon

Fred Alger Management’s Oric Pharmaceuticals ORIC Stock Holding History

Fred Alger Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,286
Closed -$774K – 484
2025
Q2 		$774K Sell
76,286
-102,436
-57% -$688K ﹤0.01% 371
2025
Q1 		$997K Sell
178,722
-40,554
-18% -$355K 0.01% 329
2024
Q4 		$1.77M Sell
219,276
-171
-0.1% -$1.57K 0.01% 338
2024
Q3 		$2.25M Buy
219,447
+63,535
+41% +$628K 0.01% 317
2024
Q2 		$1.1M Sell
155,912
-64,031
-29% -$573K 0.01% 354
2024
Q1 		$3.02M Buy
+219,943
New +$2.61M 0.02% 306

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Fred Alger Management's ORIC Position: Q3 2025 in Review

Fred Alger Management sold out of Oric Pharmaceuticals (ORIC) in Q3 2025, closing a stake of 76,286 shares — an estimated $774K sold.

Fred Alger Management first reported a position in ORIC in Q1 2024 and held it in 6 quarters. The position peaked at $3.02M in Q1 2024. 152 funds tracked by Wall St. Rank hold ORIC as of Q3 2025.

  • Fred Alger Management reported no remaining Oric Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Fred Alger Management sold 76,286 Oric Pharmaceuticals shares in Q3 2025, an estimated $774K.
  • Fred Alger Management first reported a position in Oric Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Fred Alger Management's Oric Pharmaceuticals position peaked at $3.02M in Q1 2024.
  • 152 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2025.

Based on Fred Alger Management's 13F filing for Q3 2025, filed 14 Nov 2025.